Door-to-door mobilization of COVID-19 vaccination in Kenya

How to cite

Wong, Wendy; Rosenzweig, Leah; Kremer, Michael; Maffioli, Elisa; Carney, Kevin. 2022. "Door-to-door mobilization of COVID-19 vaccination in Kenya." AEA RCT Registry. AEARCTR-0009743. https://doi.org/10.1257/rct.9743-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Wendy Wong* , Leah Rosenzweig , Michael Kremer , Elisa Maffioli , Kevin Carney

* Primary investigator

Registry ID
AEARCTR-0009743
DOI
https://doi.org/10.1257/rct.9743-1.0
First registered
Last updated
Status
On going
Trial dates
2022-07-12 – 2022-08-06
Countries
Private
Registry record
http://www.socialscienceregistry.org/trials/9743

Abstract

This study examines how being offered the COVID-19 vaccine from a nurse conducting a home visit affects vaccine uptake compared to the standard open offer of vaccination at health facilities. In collaboration with Kisumu County Health Department, this project sends nurses to conduct home visits and inform residents that they are offering the vaccine at a nearby location in the community. Participants are randomly assigned to nurse visits that are unannounced or announced in advance by enumerators conducting a household survey. The study will examine whether there are differences in vaccination rates when information about the visit is provided in advance. The primary outcome of interest is vaccination rate, comparing both vaccination rates between the groups that received a home visit (announced and unannounced) from a nurse, and each nurse visit group to a control group where people can access vaccines at a local health facility.

Intervention

T1) Respondents are told by enumerators at the end of a household survey that a nurse is coming to offer them the COVID-19 vaccine – the nurse visits the household shortly after the end of the survey to offer the vaccine. (Announced)
T2) Respondents are not told that the nurse is coming – the nurse visits the household shortly after the end of the survey to offer the vaccine. (Unannounced)
T3) Respondents are not visited by the nurse. (Control/Status Quo)
T4) Respondents are not surveyed and visited by the nurse without prior announcement. (Nurse only)

Experimental design

The study will survey 2500 households in Kisumu County in Kenya. An enumerator will conduct a survey to collect information on intentions to obtain a COVID-19 vaccine. At the end of the survey, enumerators will either not announce (T1/Unannounced) or announce (T2/Announced) to survey respondents that a nurse will arrive shortly to provide a COVID-19 vaccination. After the survey, the nurse will arrive for the home visit to offer administering the vaccine to household members at a nearby vaccination site that is within minutes walking distance. The choice to use nurses to mobilize participants to get vaccinated at a nearby site, rather than administer the vaccine door-to-door, was in order to follow government regulations of vaccine transportation.

The study will also compare vaccine uptake in households that receive a nurse visit (T1 & T2) with the status quo policy, where surveyed households are not visited by a nurse but can access the vaccine at a local health facility or community campaign (T3/Control).

There is also a fourth comparison group of households who are not surveyed by enumerators, but are visited by the nurse without prior announcement and offered the vaccine (T4/Nurse Only). The vaccination rate in this group will be compared to T1/unannounced, and if no differences are found, the two groups will be pooled in some analyses.

Design details

Randomization method
In each village, thirty households were randomly selected using an office computer and randomly assigned to a treatment group, which was done in the office by a computer. The sampling procedure preferenced the selection of (i) pregnant women, (ii) people aged 50 years and older, while maintaining gender balance (50% men and 50% women) in each village.
Randomization unit
Individual
Clusters
0
Observations
3000 (2500 who are surveyed and allocated to T1-T3; 500 who are not surveyed but visited by a nurse in T4)
Arms
Sample size for T1/Announced: 850 Sample size for T2/Unannounced: 850 Sample size for T3/Control: 800 Sample size for T4/Nurse Only: 500
Primary outcomes
Rates of COVID-19 vaccination. The primary outcome is COVID-19 vaccination rate, which will be measured at different points in time. Any additional jab/dose of the vaccine, including booster shot(s), will be included in the calculation. Rates of vaccination will be measured in the immediate- (day of), short- (1 week), medium- (1 month), and long-term (3 months) from the last day of the intervention. Rates of vaccination for each treatment group will be calculated as the number of vaccines accepted and administered as a share of the total sample size of the treatment group.
Secondary outcomes
The study will also examine additional outcomes, including: Respondent's stated willingness to get vaccinated; Rate of finding the target respondent at home when the nurse visits; Additional household members’ vaccination behavior; Difference between stated intention to vaccinate and actual acceptance of the vaccine (for T1 & T2).

Cited by

No citation data available for this registration yet.

Keywords